Lipid storage myopathy

Current Neurology and Neuroscience Reports

Volumn 11, Issue 1, 2011, Pages 97-103

  Liang, Wen Chen ^a,b   Nishino, Ichizo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Lipid storage myopathy; Multiple acyl coenzyme A dehydrogenase deficiency; Neutrolipid storage disease; Primary carnitine deficiency

Indexed keywords

CARNITINE; ELECTRON TRANSFERRING FLAVOPROTEIN; ORGANIC CATION TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOFLAVIN;

ABHD5 GENE; ARTICLE; BRAIN DISEASE; CARDIOMYOPATHY; CARNITINE DEFICIENCY; CONGENITAL MALFORMATION; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; ETFA GENE; ETFB GENE; ETFDH GENE; GENE MUTATION; GENETIC ANALYSIS; HEPATOMEGALY; HUMAN; LIPID STORAGE; LIPID STORAGE MYOPATHY; LIPIDOSIS; MULTIPLE ACYL COA DEHYDROGENASE DEFICIENCY; MYOPATHY; NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS; NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NONHUMAN; PNPLA2 GENE; SLC22A5 GENE;

ACYL-COA DEHYDROGENASE; CARNITINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; LIPID METABOLISM; LIPID METABOLISM, INBORN ERRORS; MUSCLE, SKELETAL; MUSCULAR DISEASES; SKIN DISEASES;

EID: 79551556061     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0154-y     Document Type: Article

References (38)

1. C Bruno S Dimauro 2008 Lipid storage myopathies Curr Opin Neurol 21 601 606 1:CAS:528:DC%2BD1cXht1aqt7vF 10.1097/WCO.0b013e32830dd5a6 18769256
2. J Nezu I Tamai A Oku, et al. 1999 Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter Nat Genet 21 91 94 1:CAS:528:DyaK1MXltlWjsQ%3D%3D 10.1038/5030 9916797 (Pubitemid 29036290)
3. S Vermeire P Rutgeerts 2005 Current status of genetics research in inflammatory bowel disease Genes Immun 6 637 645 1:CAS:528:DC%2BD2MXht1Gqs7jE 16107869
4. AA Yamak F Bitar P Karam, et al. 2007 Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation Clin Genet 72 59 62 1:STN:280:DC%2BD2sznvVWmtQ%3D%3D 10.1111/j.1399-0004.2007. 00814.x 17594400 (Pubitemid 47010148)
5. Y Wang SH Korman J Ye, et al. 2001 Phenotype and genotype variation in primary carnitine deficiency Genet Med 3 387 392 1:CAS:528:DC%2BD3MXpt12gs7g%3D 10.1097/00125817-200111000-00002 11715001
6. AW El-Hattab FY Li J Shen, et al. 2010 Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects Genet Med 12 19 24 1:CAS:528:DC%2BC3cXpsFGgug%3D%3D 10.1097/GIM.0b013e3181c5e6f7 20027113
7. RS Rijlaarsdam FJ van Spronsen MT Bink-Boelkens, et al. 2004 Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence Pacing Clin Electrophysiol 27 675 676 10.1111/j.1540-8159.2004.00507.x 15125729 (Pubitemid 38648462)
8. N Makhseed HD Vallance M Potter, et al. 2004 Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy J Inherit Metab Dis 27 778 780 1:CAS:528:DC%2BD2cXovVOjsLs%3D 10.1023/B:BOLI.0000045837.23328.f4 15617188 (Pubitemid 39433606)
9. C Amat di San Filippo MR Taylor L Mestroni, et al. 2008 Cardiomyopathy and carnitine deficiency Mol Genet Metab 94 162 166 1:CAS:528: DC%2BD1cXmtVSgtb8%3D 10.1016/j.ymgme.2008.02.002 18337137
10. AM Lamhonwah SE Olpin RJ Pollitt, et al. 2002 Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy Am J Med Genet 111 271 284 10.1002/ajmg.10585 12210323 (Pubitemid 34815450)
11. A Ohkuma S Noguchi H Sugie, et al. 2009 Clinical and genetic analysis of lipid storage myopathies Muscle Nerve 39 333 342 10.1002/mus.21167 19208393
12. F Scaglia Y Wang RH Singh, et al. 1998 Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency Genet Med 1 34 39 1:CAS:528:DyaK1MXjtl2ltg%3D%3D 10.1097/00125817-199811000-00008 11261427
13. R Ringseis S Ludi F Hirche, et al. 2008 Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats Pharmacol Res 58 58 64 1:CAS:528:DC%2BD1cXhtVygtLbE 10.1016/j.phrs.2008.06.006 18620058
14. G Wen R Ringseis K Eder 2010 Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron Biochem Pharmacol 79 768 776 1:CAS:528:DC%2BD1MXhsFynsrzN 10.1016/j.bcp.2009.10.002 19819229
15. C Amat di San Filippo M Pasquali N Longo 2006 Pharmacological rescue of carnitine transport in primary carnitine deficiency Hum Mutat 27 513 523 10.1002/humu.20314 16652335 (Pubitemid 43865723)
16. M Schiff R Froissart RK Olsen, et al. 2006 Electron transfer flavoprotein deficiency: functional and molecular aspects Mol Genet Metab 88 153 158 1:CAS:528:DC%2BD28Xks1Wrtrc%3D 10.1016/j.ymgme.2006.01.009 16510302
17. WC Liang A Ohkuma YK Hayashi, et al. 2009 ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency Neuromuscul Disord 19 212 216 10.1016/j.nmd.2009.01.008 19249206
18. TK Er WC Liang JG Chang, et al. 2010 High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency Clin Chim Acta 411 690 699 1:CAS:528:DC%2BC3cXktVShtrk%3D 10.1016/j.cca.2010.01.033 20138856
19. LK Law NL Tang J Hui, et al. 2009 Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency Clin Chim Acta 404 95 99 1:CAS:528:DC%2BD1MXmtlKgtb0%3D 10.1016/j.cca.2009.02.015 19265687
20. Lan MY, Fu MH, Liu YF, et al.: High frequency of ETFDH c.250G> A mutation in Taiwanese patients with late-onset lipid storage myopathy. Clin Genet 2010 Mar 29 [Epub ahead of print].
21. B Angle BK Burton 2008 Risk of sudden death and acute life-threatening events in patients with glutaric acidemia type II Mol Genet Metab 93 36 39 1:CAS:528:DC%2BD2sXhsVCjsb7P 10.1016/j.ymgme.2007.09.015 17977044 (Pubitemid 350245619)
22. M Singla G Guzman AJ Griffin, et al. 2008 Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature Pediatr Cardiol 29 446 451 10.1007/s00246-007-9119-6 17912479 (Pubitemid 351414878)
23. RK Olsen BS Andresen E Christensen, et al. 2003 Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency Hum Mutat 22 12 23 1:CAS:528:DC%2BD3sXmtVanur4%3D 10.1002/humu.10226 12815589 (Pubitemid 36807768)
24. Y Yotsumoto Y Hasegawa S Fukuda, et al. 2008 Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2 Mol Genet Metab 94 61 67 1:CAS:528:DC%2BD1cXkvFWnsrY%3D 10.1016/j.ymgme.2008.01.002 18289905
25. BJ Henriques JV Rodrigues RK Olsen, et al. 2009 Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation J Biol Chem 284 4222 4229 1:CAS:528:DC%2BD1MXhsFKqur4%3D 10.1074/jbc.M805719200 19088074 This study helps to elucidate the role of flavinylation in the pathogenesis of MADD
26. RK Olsen SE Olpin BS Andresen, et al. 2007 ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency Brain 130 2045 2054 10.1093/brain/awm135 17584774 This article first discloses that RR-MADD is mostly caused by the mutations in ETFDH (Pubitemid 47236622)
27. K Gempel H Topaloglu B Talim, et al. 2007 The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene Brain 130 2037 2044 10.1093/brain/awm054 17412732 (Pubitemid 47236610)
28. C Antozzi B Garavaglia M Mora, et al. 1994 Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency Neurology 44 2153 2158 1:STN:280:DyaK2M%2FmtVSjug%3D%3D 7969976
29. E Gianazza L Vergani R Wait, et al. 2006 Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient Electrophoresis 27 1182 1198 1:CAS:528:DC%2BD28Xjt1Sns7k%3D 10.1002/elps.200500687 16470778
30. M Schweiger A Lass R Zimmermann, et al. 2009 Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5 Am J Physiol Endocrinol Metab 297 E289 E296 1:CAS:528:DC%2BD1MXhtVahsbnO 10.1152/ajpendo.00099.2009 19401457 This article summarizes recent findings with the goal of relating structural variants of ATGL and CGI-58 to functional consequences in lipid metabolism
31. ML Dorfman C Hershko S Eisenberg, et al. 1974 Ichthyosiform dermatosis with systemic lipidosis Arch Dermatol 110 261 266 1:STN:280:DyaE2czgt1CrtQ%3D%3D 10.1001/archderm.110.2.261 4277517
32. I Chanarin A Patel G Slavin, et al. 1975 Neutral-lipid storage disease: a new disorder of lipid metabolism Br Med J 1 553 555 1:CAS:528: DyaE2MXhtlOitr8%3D 10.1136/bmj.1.5957.553 1139147
33. RA Igal JM Rhoads RA Coleman 1997 Neutral lipid storage disease with fatty liver and cholestasis J Pediatr Gastroenterol Nutr 25 541 547 1:STN:280:DyaK1c%2FisVGhug%3D%3D 10.1097/00005176-199711000-00011 9360211 (Pubitemid 27463293)
34. A Ohkuma I Nonaka MC Malicdan, et al. 2008 Distal lipid storage myopathy due to PNPLA2 mutation Neuromuscul Disord 18 671 674 10.1016/j.nmd.2008.06.382 18657972
35. C Lefevre F Jobard F Caux, et al. 2001 Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome Am J Hum Genet 69 1002 1012 1:CAS:528: DC%2BD3MXotlGitL8%3D 10.1086/324121 11590543 (Pubitemid 33015815)
36. J Fischer C Lefevre E Morava, et al. 2007 The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy Nat Genet 39 28 30 1:CAS:528:DC%2BD28XhtlGktLjL 10.1038/ng1951 17187067 This study documents the identification of causative gene of NLSDM (Pubitemid 46026498)
37. M Schweiger G Schoiswohl A Lass, et al. 2008 The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding J Biol Chem 283 17211 17220 1:CAS:528:DC%2BD1cXntFSntLw%3D 10.1074/jbc.M710566200 18445597
38. G Haemmerle A Lass R Zimmermann, et al. 2006 Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase Science 312 734 737 1:CAS:528:DC%2BD28XktVGntL4%3D 10.1126/science.1123965 16675698